Advertisement
Screener

SUTRO BIOPHARMA, INC. (STRO) ROA

SUTRO BIOPHARMA, INC. (STRO) ROA

  • 2026-06-30: ROA -92.89%.
  • 2026-03-31: ROA -63.48%.
  • 2025-12-31: ROA -109.93%.
  • 2025-09-30: ROA -103.39%.

Complete source-backed roa history.

Available history
2017-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-92.89%
2026-03-31-63.48%
2025-12-31-109.93%
2025-09-30-103.39%
2025-06-30-79.55%
2025-03-31-76.29%
2024-12-31-58.74%
2024-09-30-27.43%
2024-06-30-25.45%
2024-03-31-28.50%
2023-12-31-22.69%
2023-09-30-39.94%
2023-06-30-30.69%
2023-03-31-36.35%
2022-12-31-29.29%
2022-09-30-30.63%
2022-06-30-34.79%
2022-03-31-37.64%
2021-12-31-30.91%
2021-09-30-34.18%
2021-06-30-21.93%
2021-03-31-11.96%
2020-12-31-8.15%
2020-09-30-16.55%
2020-06-30-29.14%
2020-03-31-80.94%
2019-12-31-76.23%
2019-09-30-24.73%
2019-06-30-21.06%
2019-03-31-18.53%
2018-12-31-15.83%
2018-09-30-33.90%

Annual ROA

DateROA
2025-12-31-109.93%
2024-12-31-58.74%
2023-12-31-22.69%
2022-12-31-29.29%
2021-12-31-30.91%
2020-12-31-8.15%
2019-12-31-76.23%
2018-12-31-15.83%
2017-12-31-48.29%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Invivyd, Inc. (IVVD)United States$0.270B-2.42
PALISADE BIO, INC. (PALI)United States$0.275B-11.41
Lexeo Therapeutics, Inc. (LXEO)United States$0.278B-4.19
Lineage Cell Therapeutics, Inc. (LCTX)United States$0.241B-10.35
FATE THERAPEUTICS INC (FATE)United States$0.280B-2.51
Liminatus Pharma, Inc. (LIMN)United States$0.282B
Aligos Therapeutics, Inc. (ALGS)United States$0.238B-0.47
Inhibikase Therapeutics, Inc. (IKT)United States$0.296B-4.44
X4 Pharmaceuticals, Inc (XFOR)United States$0.297B-4.99
Protalix BioTherapeutics, Inc. (PLX)$0.221B9.87